Investor's Business Daily on MSN3mon
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter BeatEarnings edged up 1.7% to $3 per share, beating the Street's call for $2.91. Profit took a 4-cent negative hit due to a tax ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback